{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpodcasts.prevmedhealth.com%2Fepisodes%2Fmetformin-dementia-part-3-review-qHg72toA","width":444,"version":"1.0","type":"rich","title":"Metformin & Dementia part 3: Review","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/3512c98c-c29a-485f-8f25-7fec2feffd3f/a81dc18f-f492-4ff9-8687-10269f957b1f/metformin-dementia-part-3.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/1b65bb96-67a3-4bbc-9ab1-95b89487ce66\" height=\"200\" width=\"100%\" title=\"Metformin &amp; Dementia part 3: Review\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"This is the 3rd video in a series on Metformin and dementia. I review the details of several articles describing original research. The details of the science would indicate that metformin is probably neuroprotective. \nAny study showing metformin as a risk for neurodegeneration would have to go into detail about how it avoided the obvious potential confounding of diabetes, the major known cause of dementia."}